CA2116253A1 - Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant - Google Patents

Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant

Info

Publication number
CA2116253A1
CA2116253A1 CA 2116253 CA2116253A CA2116253A1 CA 2116253 A1 CA2116253 A1 CA 2116253A1 CA 2116253 CA2116253 CA 2116253 CA 2116253 A CA2116253 A CA 2116253A CA 2116253 A1 CA2116253 A1 CA 2116253A1
Authority
CA
Canada
Prior art keywords
retroviral vector
hiv
cells
seq
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2116253
Other languages
English (en)
Inventor
Jagdeesh Pyati
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Pharmaceutical Corp
Original Assignee
Ortho Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharmaceutical Corp filed Critical Ortho Pharmaceutical Corp
Publication of CA2116253A1 publication Critical patent/CA2116253A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CA 2116253 1993-02-25 1994-02-23 Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant Abandoned CA2116253A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US2193693A 1993-02-25 1993-02-25
US08/21,936 1993-02-25
US08/190,350 1994-02-01

Publications (1)

Publication Number Publication Date
CA2116253A1 true CA2116253A1 (fr) 1994-08-26

Family

ID=21806956

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2116253 Abandoned CA2116253A1 (fr) 1993-02-25 1994-02-23 Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant

Country Status (3)

Country Link
CA (1) CA2116253A1 (fr)
NO (1) NO940624L (fr)
ZA (1) ZA941287B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110684745A (zh) * 2011-07-27 2020-01-14 韦克塔里斯公司 可用于转导真核细胞的基于病毒的载体组合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110684745A (zh) * 2011-07-27 2020-01-14 韦克塔里斯公司 可用于转导真核细胞的基于病毒的载体组合物

Also Published As

Publication number Publication date
NO940624L (no) 1994-08-26
ZA941287B (en) 1995-08-24
NO940624D0 (no) 1994-02-24

Similar Documents

Publication Publication Date Title
EP0612844A2 (fr) Vecteurs d'expression contenant des antisens inhibiteurs d'HIV et d'autres séquences nucléotidiques, vecteurs rétroviraux et rétrovirus recombinants les contenant
Rosen et al. Construction of recombinant murine retroviruses that express the human T-cell leukemia virus type II and human T-cell lymphotropic virus type III trans activator genes
US5306631A (en) Compositions and method for inhibition of HIV production
JPH10506008A (ja) ＨＩＶ−１ Ｖｐｒ 融合分子に基づいたＨＩＶビリオン中へのタンパク質ターゲッティング
JP3264281B2 (ja) Ｈｉｖパッケージング配列を含むベクター、パッケージング不全ｈｉｖベクター及びその使用
US5554528A (en) Compositions and methods for inhibition of HIV production
AU698730B2 (en) Ribozymes targeting the retroviral packaging sequence expression construct s and recombinant retroviruses containing such constructs
US5985661A (en) Anti-HIV ribozymes
Inouye et al. Potent inhibition of human immunodeficiency virus type 1 in primary T cells and alveolar macrophages by a combination anti-Rev strategy delivered in an adeno-associated virus vector
US20050214258A1 (en) Vectors for delivering viral and oncogenic inhibitors
US5847096A (en) DNA constructs encoding CD4 fusion proteins
WO1993005147A1 (fr) Particules defectives interferentes du vih avec un cd-env chimerique
US5837503A (en) Vector containing viral gene transcribed by RNA polymerase III and methods for use
AU703964B2 (en) Ribozymes targeting the retroviral packaging sequence expression constructs and recombinant retroviruses containing such constructs
US6426412B1 (en) Nucleic acids encoding human immunodeficiency virus type 1 genetic suppressor elements
CA2116253A1 (fr) Constructions d'expression contenant une sequence inhibitrice antisens de hiv ainsi que d'autres sequences nucleotidiques, vecteurs retroviraux et retrovirus recombinants en contenant
WO1998003669A9 (fr) Vecteurs d'administration d'inhibiteurs de cellules virales et oncogenes
US20050260717A1 (en) Double transdominant fusion gene and protein
US6953687B1 (en) Vectors for delivering viral and oncogenic inhibitors
US6316210B1 (en) Genetic suppressor elements against human immunodeficiency virus
AU770885B2 (en) Genetic suppressor elements against human immunodeficiency virus
AU767352B2 (en) Genetic suppressor elements against human immunodeficiency virus
AU774551B2 (en) Vectors for delivering viral and oncogenic inhibitors
Heusch Preclinical development of ribozyme gene therapy for primate lentiviruses
US20030108909A1 (en) Genetic suppressor elements against human immunodeficiency virus

Legal Events

Date Code Title Description
FZDE Dead